ReviewFrontiers in pharmacology2025

Potential therapeutic targets for ischemic stroke in pre-clinical studies: Epigenetic-modifying enzymes DNMT/TET and HAT/HDAC.

Yurou Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.